Carrier materials for spinal fusion.

[1]  J. Grauer,et al.  Comparison of Posterolateral Lumbar Fusion Rates of Grafton Putty and OP-1 Putty in an Athymic Rat Model , 2004, Spine.

[2]  M. Mochizuki,et al.  Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human bone morphogenetic protein-2 and a biodegradable carrier. , 2004, Biomaterials.

[3]  D. Grob,et al.  Ne-Osteo Bone Growth Factor for Posterolateral Lumbar Spine Fusion: Results From a Nonhuman Primate Study and a Prospective Human Clinical Pilot Study , 2004, Spine.

[4]  A. Minamide,et al.  Experimental study of carriers of bone morphogenetic protein used for spinal fusion , 2004, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[5]  Hak-Sun Kim,et al.  Evidence of Osteoinduction by Grafton Demineralized Bone Matrix in Nonhuman Primate Spinal Fusion , 2004, Spine.

[6]  Daniel H. Kim,et al.  Endoscopic Instrumented Posterolateral Lumbar Fusion with Healos and Recombinant Human Growth/Differentiation Factor-5 , 2004, Neurosurgery.

[7]  W. Friess,et al.  Collagen sponges for bone regeneration with rhBMP-2. , 2003, Advanced drug delivery reviews.

[8]  H. Seeherman,et al.  rhBMP‐2 injected in a calcium phosphate paste (α‐BSM) accelerates healing in the rabbit ulnar osteotomy model , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  T. Albert,et al.  A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions , 2003, European Spine Journal.

[10]  M. Murata,et al.  Bone augmentation using rhGDF-5-collagen composite. , 2003, Clinical oral implants research.

[11]  K. Takaoka,et al.  New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. , 2003, Biomaterials.

[12]  A. Vaccaro,et al.  The use of bioabsorbable implants in the spine. , 2003, The spine journal : official journal of the North American Spine Society.

[13]  T. Zdeblick,et al.  Is INFUSE Bone Graft Superior to Autograft Bone? An Integrated Analysis of Clinical Trials Using the LT-CAGE Lumbar Tapered Fusion Device , 2003, Journal of spinal disorders & techniques.

[14]  K. Takaoka,et al.  Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. , 2003, Bone.

[15]  Willi Paul,et al.  Ceramic Drug Delivery: A Perspective , 2003, Journal of biomaterials applications.

[16]  Hak-Sun Kim,et al.  Simple Carrier Matrix Modifications Can Enhance Delivery of Recombinant Human Bone Morphogenetic Protein-2 for Posterolateral Spine Fusion , 2003, Spine.

[17]  Y. Nakayama,et al.  Laser-Perforated Membranous Biomaterials Induced Pore Size-Dependent Bone Induction When Used as a New BMP Carrier , 2003, Connective tissue research.

[18]  S. Boden,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.

[19]  A. Weckbach,et al.  Successful Transpedicular Lumbar Interbody Fusion by Means of a Composite of Osteogenic Protein-1 (rhBMP-7) and Hydroxyapatite Carrier: A Comparison With Autograft and Hydroxyapatite in the Sheep Spine , 2002, Spine.

[20]  H. Seeherman,et al.  Retention of 125I‐labeled recombinant human bone morphogenetic protein‐2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[21]  H. Seeherman,et al.  Bone Morphogenetic Protein Delivery Systems , 2002, Spine.

[22]  D. Grob,et al.  Purified Bovine BMP Extract and Collagen for Spine Arthrodesis: Preclinical Safety and Efficacy , 2002, Spine.

[23]  J. Ong,et al.  Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2. , 2002, Journal of biomedical materials research.

[24]  A. Vaccaro.  The role of the osteoconductive scaffold in synthetic bone graft. , 2002, Orthopedics.

[25]  W. Hutton,et al.  Delivery of Recombinant Human Bone Morphogenetic Protein-2 Using a Compression-Resistant Matrix in Posterolateral Spine Fusion in the Rabbit and in the Non-Human Primate , 2002, Spine.

[26]  R. Bucholz.  Nonallograft osteoconductive bone graft substitutes. , 2002, Clinical orthopaedics and related research.

[27]  R. Legeros,et al.  Properties of osteoconductive biomaterials: calcium phosphates. , 2002, Clinical orthopaedics and related research.

[28]  J. Thalgott,et al.  Anterior lumbar interbody fusion with titanium mesh cages, coralline hydroxyapatite, and demineralized bone matrix as part of a circumferential fusion. , 2002, The spine journal : official journal of the North American Spine Society.

[29]  T. Clineff,et al.  Potential of an ultraporous β-tricalcium phosphate synthetic cancellous bone void filler and bone marrow aspirate composite graft , 2001, European Spine Journal.

[30]  J. Wozney,et al.  Delivering on the promise of bone morphogenetic proteins. , 2001, Trends in biotechnology.

[31]  H. Uludaǧ,et al.  Engineering temperature-sensitive poly(N-isopropylacrylamide) polymers as carriers of therapeutic proteins. , 2001, Biotechnology and bioengineering.

[32]  I. Asahina,et al.  Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. , 2001, Biomaterials.

[33]  S. Boden.  Evaluation of carriers of bone morphogenetic protein for spinal fusion. , 2001, Spine.

[34]  K. Takaoka,et al.  Biodegradable Poly-d,l-Lactic Acid-Polyethylene Glycol Block Copolymers as a BMP Delivery System for Inducing Bone , 2001, The Journal of bone and joint surgery. American volume.

[35]  S. Goodman,et al.  Effect of osteogenic protein 1/collagen composite combined with impacted allograft around hydroxyapatite-coated titanium alloy implants is moderate. , 2001, Journal of biomedical materials research.

[36]  S. Ichinose,et al.  The biocompatibility and osteoconductive activity of a novel hydroxyapatite/collagen composite biomaterial, and its function as a carrier of rhBMP-2. , 2001, Journal of biomedical materials research.

[37]  Manohar M. Panjabi,et al.  Evaluation of OP-1 as a Graft Substitute for Intertransverse Process Lumbar Fusion , 2001, Spine.

[38]  A. Vaccaro,et al.  The Use of Allograft Bone in Lumbar Spine Surgery , 2000, Clinical orthopaedics and related research.

[39]  P. Chistolini,et al.  Biomechanical evaluation of cell-loaded and cell-free hydroxyapatite implants for the reconstruction of segmental bone defects , 1999, Journal of materials science. Materials in medicine.

[40]  L. Titus,et al.  Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. , 1999, Spine.

[41]  P. Chakravarthy,et al.  alpha-BSM: a biomimetic bone substitute and drug delivery vehicle. , 1999, Clinical orthopaedics and related research.

[42]  H. Uludaǧ,et al.  Carrier systems for bone morphogenetic proteins. , 1999, Clinical orthopaedics and related research.

[43]  H. Parvataneni,et al.  Bone grafting for spinal fusion. , 1999, The Orthopedic clinics of North America.

[44]  J. Wozney,et al.  Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers. , 1999, Spine.

[45]  D. Bradford,et al.  Calcium sulfate- and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone. , 1999, The Orthopedic clinics of North America.

[46]  H. Uludaǧ,et al.  Characterization of absorbable collagen sponges as rhBMP-2 carriers. , 1999, International journal of pharmaceutics.

[47]  S. Boden,et al.  Posterolateral Lumbar Intertransverse Process Spine Arthrodesis With Recombinant Human Bone Morphogenetic Protein 2/Hydroxyapatite‐Tricalcium Phosphate After Laminectomy in the Nonhuman Primate , 1999, Spine.

[48]  L. Titus,et al.  New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. , 1999, Spine.

[49]  J. Fischgrund,et al.  The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP‐2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion Model , 1999, Spine.

[50]  K E Healy,et al.  Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. , 1998, Journal of biomedical materials research.

[51]  H. Ohgushi,et al.  BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. , 1998, Journal of biomedical materials research.

[52]  J. Wozney,et al.  Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. , 1997, Journal of spinal disorders.

[53]  M. Chapman,et al.  Treatment of Acute Fractures with a Collagen-Calcium Phosphate Graft Material. A Randomized Clinical Trial*† , 1997, The Journal of bone and joint surgery. American volume.

[54]  H. Ozawa,et al.  Long-term evaluation of recombinant human bone morphogenetic protein-2 induced bone formation with a biologic and synthetic delivery system. , 1996, The British journal of oral & maxillofacial surgery.

[55]  G. Muschler,et al.  Evaluation of Collagen Ceramic Composite Graft Materials in a Spinal Fusion Model , 1996, Clinical orthopaedics and related research.

[56]  K. Leong,et al.  Poly(α-hydroxy acids). Carriers for bone morphogenetic proteins , 1996 .

[57]  M. Urist,et al.  Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): a substitute for autogeneic bone grafts. , 1996, The Journal of oral implantology.

[58]  I. Ono,et al.  Efficacy of hydroxyapatite ceramic as a carrier for recombinant human bone morphogenetic protein. , 1995, The Journal of craniofacial surgery.

[59]  K. Takaoka,et al.  Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein. , 1993, Clinical orthopaedics and related research.

[60]  M. Asselmeier,et al.  A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus , 1993, The American journal of sports medicine.

[61]  J. Zerwekh,et al.  Fibrillar collagen‐biphasic calcium phosphate composite as a bone graft substitute for spinal fusion , 1992, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[62]  K. Takaoka,et al.  Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. , 1992, Clinical orthopaedics and related research.

[63]  K Ono,et al.  Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. , 1988, Clinical orthopaedics and related research.

[64]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.